Pfizer Inc (PFE)

Pharmaceutical Preparations

Latest Price

$28.52

TTM P/E

37.53

Normalized P/E

11.89

Div Yield

6.03%

Book Value

14.95

P/B Ratio

1.91

Valuation metrics

EPS: $1.36

Book value / share: $15.14

Formula: √(22.5 × EPS × BVPS)

Graham Number

$21.52

25% downside

Norm. op. income: $11.1B (median of 7yr)

Tax rate: 8%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$8.30

71% downside

Base FCF: $9.8B (median of recent 5yr)

Growth: 4%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$18.61

35% downside

EPS: $1.36

Target P/E: 12×

Formula: EPS × P/E

P/E Fair Value

$16.32

43% downside

67.9% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	529.67M	$12.75B	9.30%	+31.41M	2026-06-30
Vanguard Capital Management LLC	372.15M	$8.96B	6.53%	+2.72M	2026-06-30
State Street Corp	307.09M	$7.39B	5.39%	+5.50M	2026-06-30
Geode Capital Management, LLC	135.28M	$3.25B	2.38%	+1.71M	2026-06-30
Vanguard Portfolio Management LLC	119.24M	$2.87B	2.09%	+2.50M	2026-06-30
Fisher Asset Management, LLC	109.07M	$2.63B	1.92%	+4.10M	2026-06-30
Morgan Stanley	96.35M	$2.32B	1.69%	+3.66M	2026-06-30
Norges Bank	61.51M	$1.48B	1.08%	-12.03M	2026-06-30
Northern Trust Corp	59.08M	$1.42B	1.04%	-2.94M	2026-06-30
Bank of New York Mellon Corp	57.88M	$1.39B	1.02%	+4.00M	2026-06-30